Cylex Inc. Signs Agreement with Dynal Biotech.Business Editors/Health & Medical Writers BIOWIRE2K COLUMBIA, Md.--(BW HealthWire)--Oct. 24, 2001 Cylex Incorporated, a privately held Company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. , announced today that it has entered into an agreement with Dynal Biotech A.S.A of Oslo, Norway for Dynal Biotech to supply Dynabeads(R) to Cylex for use in conjunction with Cylex's patented(a) In Vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. CMI (Computer-Managed Instruction) Using computers to organize and manage an instructional program for students. It helps create test materials, tracks the results and monitors student progress. (TM) technology for the measurement of cell mediated immunity. The combination of Dynal Biotech and Cylex technologies creates a unique capability of sorting specific subsets of human blood cells blood cells, n.pl the formed elements of the blood, including red cells (erythrocytes), white cells (leukocytes), and platelets (thrombocytes). blood cells See erythrocyte and leukocyte. Platelets are classed separately. and analyzing them in terms of their immune function Immune function The state in which the body recognizes foreign materials and is able to neutralize them before they can do any harm. Mentioned in: Herbalism, Traditional Chinese, Stress Reduction . This becomes a powerful diagnostic tool for understanding patient immune status in a variety of important areas of health care. Cylex's President, Dr. Judith Britz, commented, "Cylex is pleased to have Dynal Biotech as a supplier of its magnetic beads. Dynal Biotech's experience in making beads for medical uses is synergistic with Cylex's line of cell mediated immunity products." Dynal Biotech's President, Vigdis Heggeli, commented, "Dynal Biotech is also delighted to be Cylex's partner of choice as they move towards the exciting area of immune status monitoring as this complements Dynal's long term strategy of working towards cell therapy and diagnostics." Dynal Biotech ASA Asa (ā`sə), in the Bible, king of Judah, son and successor of Abijah. He was a good king, zealous in his extirpation of idols. When Baasha of Israel took Ramah (a few miles N of Jerusalem), Asa bought the help of Benhadad of Damascus and is a privately held Norwegian biotechnology company and a leader in the research, development and manufacture of magnetic bead products, sold under the well-known brand name, Dynbabead(R). Dynabeads(R) are uniform superparamagnetic polystyrene beads. Coated with one or more antibodies specific to receptors on cell surfaces, these qualities enable the beads to bind to to contract; as, to bind one's self to a wife s>. See also: Bind specific cells from a heterogeneous mixture of cells such as human blood. Dynabeads(R) are widely used in cellular biology cellular biology n. The study of the molecular or chemical interactions of biological phenomena. in both research and therapy because they are highly specific and leave cells viable. Cylex is a bioscience Company dedicated to developing products that will enable physicians to evaluate the efficacy of drug therapy and the immune status of patients. Cylex's patented technology provides an innovative approach for measuring the activity of the immune system. Products based on this new technology can be used to perform immune function assessment in transplant recipients, in the monitoring of AIDS patients, cancer, autoimmunity and other infectious diseases. It is expected that the technology will be a valuable adjunct in the development of vaccines as well as new therapeutic drugs that impact the immune system. The Company's tests are currently available for research use only. Cylex currently has a clinical application pending FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. clearance. The Company can be contacted at (410) 964-0236 or contact@cylex.net. Additional information is available on the Company's Web Site www.cylex.net. Dynal Biotech can be contacted at 1 (800) 638-9416 or techcenter@dynalbiotech.com. Additional information is available on Dynal Biotech's Web Site www.dynalbiotech.com. (a) U.S. Patent Number: 5,773,232 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion